FivePrime Therapeutics

FivePrime Therapeutics
Based: South San Francisco, CA
Founded: 2001

Why It's Fierce: FivePrime's business plan centers on swift and aggressive drug discovery work. The company has a new method for identifying therapeutics. It uses a sophisticated, high-throughput approach to assaying and isolating primarily therapeutic proteins. FivePrime is leveraging what it calls the Pharmanome, the entire set of pharmaceutically relevant genes and proteins. Just last summer the company hired Gail Maderis to take over as CEO. The former Genzyme oncology chief wasted no time advancing the company's work screening secreted proteins for programs that range from Type 2 diabetes and cancer to autoimmune and inflammatory diseases.

What to look for: This company is actively looking for partnerships in protein therapeutics and antibodies. And, no surprise, it intends to move swiftly.

FivePrime Therapeutics

Suggested Articles

Researchers are studying the retrovirus KoRV-A, which is spreading among koalas, to gain new insights into how DNA evolves.

Shionogi and Hsiri Therapeutics first joined forces last year in a licensing and R&D deal focused on tuberculosis and non-tuberculous lung infections.

The efficacy results suggest the experimental oral therapy, abrocitinib, has a shot at challenging the blockbuster biologic incumbent.